Conference Abstracts

Advances in Pulmonary Hypertension

关键词: Cardiology;    Rheumatology;    Psychosocial Issues;    WHO Group 1- Pulmonary Arterial Hypertension;    WHO Group 4;    Anatomy;    Physiology/Pathophysiology;    symptoms;    Gender;    PH;    Research;    Qualityof Life;    Exercise;    Support;    Associated Diseases;    Connective Tissue Diseases;    Scleroderma;    diastolic dysfunction;    Chronic thromboembolic pulmonary hypertension;    Medication Adherence;    nitric oxide;    Anticoagulation;    Diuretics;    thromboendarterectomy;    Preserved ejection fraction;    endothelial proliferation;    endothelial dysfunction;    Micro Particles;    Testosterone;    patient-reported outcomes;    Animal Models of PH;    Monocrotaline rat model;    Classification;   

DOI  :  

学科分类：医学（综合）

来源: Pulmonary Hypertension Association

【 摘 要 】

The method we have used to assess the global impact of PVDs in the world is very simple. We have tried to assess the proportion of patients who are likely to develop PVDs of various clinical conditions from the published data.This will help us to predict the potential prevalence of PVDs in these conditions globally, based on the global number of patients affected. This is a controversial method, as it could be considered subject to too much guesswork; but at present it appears to be the only method available, due to the scarcity of hard data. It is to be hoped that future studies will be able to confirm or refute the picture painted by our estimate.

【 授权许可】

All Rights reserved